Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia

Emily M. McWilliams, Jennifer M. Mele, Carolyn Cheney, Elizabeth A. Timmerman, Faraz Fiazuddin, Ethan J. Strattan, Xiaokui Mo, John C. Byrd, Natarajan Muthusamy, Farrukh T. Awan

Research output: Contribution to journalArticlepeer-review

104 Scopus citations

Fingerprint

Dive into the research topics of 'Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences